ONCLIVE NEWS NETWORK: ON LOCATION WILL BE LIVE AT ESMO THIS WEEK - STAY TUNED FOR MORE INFORMATION!

Dr. Mark Kris on Performance Status in Lung Cancer

Mark G. Kris, MD
Published: Wednesday, Jan 09, 2013

Mark G. Kris, MD, chief of the Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center, discusses the importance of accurately determining a patient's performance status.

Kris says that there are so many things involved in the care of a lung cancer patient that it may be easy to forget to determine their performance status.

Physicians must ask a patient what activities they can and cannot do, whether or not they can go to work and should not visually "estimate" answers. As a part of the assessment of performance status, the get-up-and-go test is extremely telling. The get-up-and-go test requires a patient to stand up from a chair, walk 10 feet, turn around, walk back to the chair and sit down. A physician can hone in on the patient's performance status based on whether he or she took 10 seconds or more to complete the task.

Mark G. Kris, MD, chief of the Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center, discusses the importance of accurately determining a patient's performance status.

Kris says that there are so many things involved in the care of a lung cancer patient that it may be easy to forget to determine their performance status.

Physicians must ask a patient what activities they can and cannot do, whether or not they can go to work and should not visually "estimate" answers. As a part of the assessment of performance status, the get-up-and-go test is extremely telling. The get-up-and-go test requires a patient to stand up from a chair, walk 10 feet, turn around, walk back to the chair and sit down. A physician can hone in on the patient's performance status based on whether he or she took 10 seconds or more to complete the task.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 18th Annual International Lung Cancer Congress®Oct 31, 20181.5
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Publication Bottom Border
Border Publication
x